Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancer Research|February 1, 1983
Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acidR L Stolfi, D S Martin, R C Sawyer, et al.Pharmaceutical Research|November 27, 2013
Effect of Uridine on the Metabolism of 5-Fluorouracil in the CD8F 1 Murine Mammary Carcinoma SystemR C Sawyer, R L Stolfi, S Spiegelman, et al.Biochemical Pharmacology|July 15, 1989
Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNAR C Sawyer, R L Stolfi, D S Martin, et al.Pharmaceutical Research|October 1, 1989
Effect of uridine diphosphoglucose on levels of 5-phosphoribosyl pyrophosphate and uridine triphosphate in murine tissuesJ R Colofiore, R C Sawyer, M E Balis, et al.Journal of the National Cancer Institute|March 2, 1988
Chemotherapeutic evaluation using clinical criteria in spontaneous, autochthonous murine breast tumorsR L Stolfi, L M Stolfi, R C Sawyer, et al.Cancer Research|August 1, 1980
Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumorsR L Stolfi, R C Sawyer, R Nayak, et al.Cancer Research|October 1, 1983
Improved therapeutic index with sequential N-phosphonacetyl-L-aspartate plus high-dose methotrexate plus high-dose 5-fluorouracil and appropriate rescueD S Martin, R L Stolfi, R C Sawyer, et al.Cancer Research|October 1, 1982
High-dose 5-fluorouracil with delayed uridine "rescue" in miceD S Martin, R L Stolfi, R C Sawyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1985
Decreased host toxicity in vivo during chronic treatment with 5-flourouracilJ W Darnowski, R C Sawyer, R L Stolfi, et al.Cancer Research|August 15, 1989
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancerN Kemeny, A Schneider, D S Martin, et al.Pageof 3